NEW YORK (GenomeWeb News) – ProQinase and Crelux have agreed to a partnership to develop and market crystal-grade protein kinases to pharmaceutical and biotechnology customers, the German companies said today.
Under the agreement, ProQinase will produce and exclusively market recombinant protein kinases that are optimized for crystallization, and Crelux will perform quality control for each crystal grade protein batch. Crelux also will continue to provide crystallization and x-ray crystallography services, the firms said.
ProQinase also will grant Crelux privileged direct access to kinase crystal-grade proteins. The companies also will offer new crystal-grade protein or crystal structures tailored for specific customers.